2016

Nomoto H, Miyoshi H, Furumoto T, Oba K, Tsutsui H, Inoue A, Atsumi T, Manda N, Kurihara Y, Aoki S. SAIS Study Group. A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1). PLoS One. 6; 11(10):e0164255, 2016.

Yamamoto C, Miyoshi H*, Ono K, et al. Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy. Endocrine J. 63(6):589-96, 2016.

Miyoshi A, Yamada M, Shida H, Miyoshi H, et al. Circulating NET levels in well-controlled type 2 diabetes and pathway involved in high-dose glucose-induced NET formation. Pathobiology. 83: 243-251, 2016.

Koyanagawa N, Miyoshi H, Ono K, Nakamura A, et al. Comparative effects of vildagliptin and sitagliptin determined by continuous glucose monitoring in patients with type 2 diabetes mellitus. Endocrine J. 31;63(8):747-53, 2016

Yamamoto C, Miyoshi H*, Atsumi T. Degludec is superior to glargine in terms of daily glycemic variability in people with type 1 diabetes mellitus. Endocrine J. 63(1):53-60, 2016.

Nakamura A, Mitsuhashi T, Takano Y, Kameda H, Nomoto H, Nagai S, Miyoshi H*, Shimizu C, Terauchi Y, Atsumi T. Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas. Endocrine J. 63(2):135-42, 2016.

Komatsu Y, Nakamura A, Takihata M, Inoue Y, Yahagi S, Tajima K, Tsuchiya H, Takano T, Yamakawa T, Yoshida M, Miyoshi H, Terauchi Y. Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia. Endocrine J. 63: 311-314, 2016

Nomoto H, Miyoshi H*. A Comparison of the effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial. Sapporo Athero-Incretin Study 2 (SAIS2). World Biomedical Frontiers ISSN: 2328-0166. 2016

佐藤三穂,佐藤仁美,三好秀明,ほか:特定機能病院における糖尿病療養支援の方向性に関する一考察:外来初診患者の臨床的特徴から 糖尿病ケア 13: 84-882016

老田真佑子,三好秀明:手指に障害がある場合は? いま知っておきたい2型糖尿病の注射療法の疑問67 南江堂 2016

 高瀬崇宏,三好秀明,ほか:短期的な血糖コントロールによる神経機能の改善効果:簡易神経電動測定機器(DPNチェックHDN-1000)を用いた検討 Diabetes Frontier Online ISSN 2188-7527 2016

大森一乃,三好秀明: Carney complex と診断し PRKAR1A 遺伝子に新規変異を認めた一例 日本内分泌学会誌 日本内分泌学会 92:18-21, 2016

山本知穂,三好秀明:認知症がある場合は? いま知っておきたい2型糖尿病の注射療法の疑問67 南江堂 2016

山本知穂,三好秀明:2型糖尿病治療―経口血糖降下薬で効果不十分例への対応 ―病棟での高血糖への対応― Medicina 医学書院 53: 96982016

山本知穂,三好秀明:2型糖尿病治療―経口血糖降下薬で効果不十分例への対応―病棟での高血糖への対応― Medicina 医学書院 53: 96982016